Andromachi (Machi) Scaradavou, MD

Areas of Expertise

Conditions I Treat

  • Pediatric cancers
  • Pediatric leukemias
  • Pediatric lymphomas

My Specialties

  • Pediatric cancer care
  • Pediatric bone marrow transplant
  • Pediatric cellular therapy
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a pediatric hematologist-oncologist on the MSK Kids team with extensive experience in the use of cord blood transplants to treat babies, children, adolescents, and young adults with leukemia, lymphoma, and other cancers as well as non-malignant blood diseases.

Umbilical cord blood from healthy newborns is an excellent source of stem cells to rebuild a patient’s immune and blood system. At MSK Kids, we try to present patients and their families with different treatment options, tailored to their individual conditions. Cord blood has a number of advantages over blood or bone marrow from an unrelated donor. It is not necessary to find a perfect HLA (tissue type) match, making it particularly attractive for patients of ethnic minorities. Cord blood is more rapidly available, and there is a lower risk of a serious transplant complication called graft-versus-host disease, which occurs when the transplanted cells attack the normal tissues of the recipient’s body.

My colleagues and I have a great deal of experience in research that has led to cord blood transplantation being brought from the laboratory to the clinic. We are also studying new ways to use cord blood to treat diseases of the blood and bone marrow.

I have spoken nationally in support of cord blood transplantation to try to get more hospitals interested in participating in cord blood donation programs. I also teach fellows and give presentations at conferences about cord blood collection and banking and its use in transplantation and cellular therapies.

What I Do at MSK

I'm a pediatric hematologist-oncologist, which is a doctor who treats cancers and blood diseases in children, adolescents, and young adults.

I'm a bone marrow transplant specialist, which is a doctor with special training in bone marrow transplants.

  • Associate Attending Physician
Areas of Expertise

Conditions I Treat

  • Pediatric cancers
  • Pediatric leukemias
  • Pediatric lymphomas
  • Blood, bone marrow, and hematologic cancers and conditions

My Specialties

  • Pediatric cancer care
  • Pediatric bone marrow transplant
  • Pediatric cellular therapy
  • Adolescent and young adult (AYA) cancer care
Education & Honors

Education

  • MD, University of Athens Medical School (Greece)

Residencies

  • Pediatrics - Massachusetts General Hospital/Harvard Medical School

Fellowships

  • Pediatric Hematology/Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Pediatarics
  • Pediatric Hematology-Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY
1275 York Avenue New York NY 10065

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Bone Marrow Transplant Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Scaradavou’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Andromachi (Machi) Scaradavou discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures